Achillion Pharmaceuticals (ACHN) Stock: Climbing On Clinical Data

Achillion Pharmaceuticals ACHN Stock News

Achillion Pharmaceuticals, Inc. (NASDAQ: ACHN) is having an incredibly strong start to the trading session this morning, and for good reason. The company announced positive clinical data, exciting investors and sending the stock for the top. Today, we’ll talk about: The data; what we’re seeing from ACHN stock as a result; and what we’ll be … Read more

Achillion Pharmaceuticals (ACHN) Stock: Gaining On Regulatory News

Achillion Pharmaceuticals, Inc.¬†(NASDAQ: ACHN) is having an overwhelmingly strong day in the market today, and for good reason. News broke of a positive opinion surrounding Orphan Drug status of one of the company’s pipeline treatments in Europe. Of course, this is leading to excitement among investors, sending the stock screaming for the top. Today, we’ll … Read more

Achillion Pharmaceuticals (ACHN) Stock: Gaining On Financial Results

Achillion Pharmaceuticals, Inc. (NASDAQ: ACHN) is having an overwhelmingly strong day in the market today, and for good reason. The company announced positive financial results for the three and six month period ending on June 30th and provided updates with regard to clinical programs. Of course, this led to excitement among investors, pushing the stock … Read more

Achillion Pharmaceuticals (ACHN) Stock: Heading Skyward On New Patnet

Achillion Pharmaceuticals, Inc. (NASDAQ: ACHN) Achillion Pharmaceuticals is having a strong start in the pre-market hours today, and for good reason. The commpany has been issued a patent. As a result, the stock is soaring, and as soon as the gains started, our partners at Trade Ideas alerted us of the movement. At the moment … Read more

Achillion Pharmaceuticals (ACHN) Climbs On Interim Odalasvir Results

Achillion Pharmaceuticals, Inc. (NASDAQ: ACHN) Achillion Pharmaceuticals is having an incredible day in the market after announcing interim results from a Phase 2 study evaluating odalasvir, an NS5A inhibitor. Today, we’ll take a look at the interim data offered by the company, how the market reacted to the news, and what we can expect to … Read more

Achillion (ACHN) & Janssen (JNJ) | Here’s The Big News We’ve Been Waiting For!

Achillion Pharmaceuticals, Inc. (NASDAQ: ACHN) Early in the week, we saw Achillion Pharmaceuticals stock soar. The reason for the climb was simple to spot. ACHN canceled an engagement at a big medical conference, but didn’t provide reason to investors. GILD also seemed to have missed the same conference. So, rumors started to fly that Gilead … Read more

Achillion Pharmaceuticals (ACHN) Stock Is On A Breakout Climb | Will Gains Last

Achillion Pharmaceuticals, Inc. (NASDAQ: ACHN) Achillion Pharmaceuticals stock is soaring in the market today. However, it seems to have caught many investors by surprise. The company planned an announcement at 2015 UBS Global Healthcare Conference that was scheduled for today. However, it seems like the reason for the cancellation is sparking a rumor that investors … Read more

Biotech News- 2/9/15 to 2/13/15

Achillion Pharmaceuticals (ACHN) Shares of Achillion gained 7% on 2/9/15 last week when it had¬†announced that it had achieved a 100% SVR12 in a phase 2 trial treating patients with the genotype 1 version of the Hepatitis C virus — HCV. The trial tested for the primary objective of patients being able to achieve a … Read more